Multisystemic inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study

Naïm Ouldali, Haleh Bagheri, Francesco Salvo, Denise Antona, Antoine Pariente, Claire Leblanc, Martine Tebacher, Joëlle Micallef, Corinne Levy, Robert Cohen, Etienne Javouhey, Brigitte Bader-Meunier, Caroline Ovaert, Sylvain Renolleau, Veronique Hentgen, Isabelle Kone-Paut, Nina Deschamps, Loïc De Pontual, Xavier Iriart, Christelle Gras-Le Guen, François Angoulvant, Alexandre Belot, the “French Covid-19 Paediatric Inflammation Consortium”, the “French Pharmacovigilance network”
doi: https://doi.org/10.1101/2022.01.17.22269263

Article Information

doi 
https://doi.org/10.1101/2022.01.17.22269263
History 
  • January 18, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Naïm Ouldali, M.D., Ph.D.1,2,3,4,#,
  2. Haleh Bagheri, Pharm.D., Ph.D.5,
  3. Francesco Salvo, M.D., Ph.D.6,7,
  4. Denise Antona, M.D.8,
  5. Antoine Pariente, M.D., Ph.D.9,
  6. Claire Leblanc, M.D.1,
  7. Martine Tebacher, M.D., Ph.D.10,
  8. Joëlle Micallef, M.D., Ph.D.11,12,
  9. Corinne Levy, M.D.3,13,
  10. Robert Cohen, M.D.3,13,
  11. Etienne Javouhey, M.D., Ph.D.14,15,
  12. Brigitte Bader-Meunier, M.D.16,17,
  13. Caroline Ovaert, M.D., Ph.D.18,19,
  14. Sylvain Renolleau, M.D., Ph.D.20,21,
  15. Veronique Hentgen, M.D., Ph.D.22,23,
  16. Isabelle Kone-Paut, M.D.23,24,
  17. Nina Deschamps, M.D.25,
  18. Loïc De Pontual, M.D., Ph.D.26,
  19. Xavier Iriart, M.D.27,28,29,
  20. Christelle Gras-Le Guen, M.D., Ph.D.30,31,32,
  21. François Angoulvant, M.D., Ph.D.1,33,
  22. Alexandre Belot, M.D., Ph.D.34,35,36,#,
  23. the “French Covid-19 Paediatric Inflammation Consortium”£,
  24. the “French Pharmacovigilance network”*
  1. 1Assistance Publique-Hôpitaux de Paris, Department of general paediatrics, paediatric infectious disease and internal medicine, Robert Debré university hospital, Université de Paris, Paris, France
  2. 2Infectious Diseases Division, CHU Sainte Justine - Montreal University, Montreal, Quebec, Canada
  3. 3ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France
  4. 4Université de Paris, INSERM UMR 1123, ECEVE, Paris, France
  5. 5Department of Medical and Clinical Pharmacology, Regional Pharmacovigilance Center, CIC 1436, Toulouse University Hospital, France
  6. 6INSERM, BPH, U1219, Team Pharmacoepidemiology, Université de Bordeaux, 33000 Bordeaux, France
  7. 7Pole de Santé Publique, Service de Pharmacologie Médicale, Regional pharmacovigilance center of Bordeaux, CHU de Bordeaux, 33000 Bordeaux, France
  8. 8Santé Publique France, Agence nationale de Santé publique, Saint-Maurice, France
  9. 9Team Pharmacoepidemiology, Bordeaux University, INSERM, U1219 BPH Research Center, Bordeaux, France
  10. 10Regional pharmacovigilance center of Strasbourg, HUS, Strasbourg, France
  11. 11Marseille University hospital, Clinical pharmacology department Regional Pharmacovigilance Center of Marseille, France
  12. 12Aix-Marseille University, INSERM UMR 1106, Marseille, France
  13. 13Centre Hospitalier Intercommunal, Research Center, Université Paris Est, IMRB-GRC GEMINI, Créteil, France
  14. 14Hospices Civils de Lyon, Paediatric Intensive Care Unit, Hopital Femme, Mère Enfant, University of Lyon, Bron, France
  15. 15EA 7426 “Pathophysiology of Injury-Induced Immunosuppression”, University Claude Bernard Lyon 1, Hospices Civils of Lyon, Lyon, France
  16. 16Department of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, AP-HP, Paris, France, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Paris, France
  17. 17Laboratory of Immunogenetics of Paediatric Autoimmunity, Imagine Institute, Inserm U 1163, Paris University, Paris, France
  18. 18Department of Pediatric Cardiology, Hôpital Timone Enfant, AP-HM, Marseille, France
  19. 19Aix-Marseille University, MMG, INSERM, Marseille, France
  20. 20Pediatric Intensive Care Unit, Necker Hospital, AP-HP, Paris University, Paris, France
  21. 21Paris University, EA7323, Paris, France
  22. 22General Pediatrics department, Versailles Hospital, Paris, France
  23. 23CEREMAIA (French reference center for auto-inflammatory diseases and inflammatory amyloidosis), Paris, France
  24. 24Pediatric Rheumatology Department, Bicêtre Hospital, APHP, University of Paris Saclay, Kremlin Bicêtre, France
  25. 25General Pediatrics department, Saint-Malo Hospital, Saint-Malo, France
  26. 26General Pediatrics and Pediatric emergency department, Jean Verdier Hospital, Bondy, France
  27. 27Department of Pediatric and Adult Congenital Cardiology, Bordeaux University Hospital, Pessac, France
  28. 28Institut Hospitalo-Universitaire Liryc, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac, Bordeaux, France
  29. 29INSERM, Centre de recherche Cardio-Thoracique de Bordeaux, Bordeaux, France
  30. 30Department of Pediatric Emergency Care, Nantes University Hospital, F-44000, Nantes, France
  31. 31Obstetrical, Perinatal and Pediatric Epidemiology Research team, Center of Research in Epidemiology and Statistics, Université de Paris, INSERM, F-75004, Paris, France
  32. 32Inserm CIC 1413, Nantes University Hospital, F-44000, Nantes, France
  33. 33INSERM, Centre de Recherche des Cordeliers, UMRS 1138, Sorbonne Université, Université de Paris, Paris, France
  34. 34Hospices Civils de Lyon, Paediatric Nephrology, Rheumatology, Dermatology, Hopital Femme, Mère Enfant, & Centre International de Recherche en Infectiologie / INSERM U1111, Bron, France
  35. 35National Reference Center for Rheumatic and AutoImmune and Systemic Diseases in Children (RAISE), Lyon, France
  36. 36International Center of Research in Infectiology, Lyon University, INSERM U1111, CNRS UMR 5308, ENS, UCBL, 69007 Lyon, France
  1. ↵#Corresponding authors:
    Naïm Ouldali, MD, PhD, Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, F-75019 Paris, France Tel.: +-33-1-40.03.20.48; Fax: +-33-1-40.03.20.43; Email: naim.ouldali{at}aphp.fr, Alexandre Belot, MD, PhD, Pediatric Nephrology, Rheumatology, Dermatology Unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, France. Tel: +33 427856481; Email: alexandre.belot{at}chu-lyon.fr
Back to top
Posted January 18, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Multisystemic inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study
Naïm Ouldali, Haleh Bagheri, Francesco Salvo, Denise Antona, Antoine Pariente, Claire Leblanc, Martine Tebacher, Joëlle Micallef, Corinne Levy, Robert Cohen, Etienne Javouhey, Brigitte Bader-Meunier, Caroline Ovaert, Sylvain Renolleau, Veronique Hentgen, Isabelle Kone-Paut, Nina Deschamps, Loïc De Pontual, Xavier Iriart, Christelle Gras-Le Guen, François Angoulvant, Alexandre Belot, the “French Covid-19 Paediatric Inflammation Consortium”, the “French Pharmacovigilance network”
medRxiv 2022.01.17.22269263; doi: https://doi.org/10.1101/2022.01.17.22269263
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area